Patents by Inventor David E. Clapham

David E. Clapham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200209259
    Abstract: Methods for identifying compounds that modulate polycystin-1/polycystin-2 (PKD1/PKD2) ion channel activity or cilium/plasma membrane trafficking are provided. Related reagents and uses of the compounds are also provided.
    Type: Application
    Filed: March 8, 2017
    Publication date: July 2, 2020
    Applicant: Children's Medical Center Corporation
    Inventors: Markus G. Delling, David E. Clapham, Julia F. Doerner
  • Publication number: 20130289520
    Abstract: The present invention provides methods and compositions for highly precise spatial and temporal control over cytosolic delivery of compounds, in particular, those compounds that would otherwise be cell-impermeable. Among other things, the present invention provides a composition for targeted drug delivery comprising a nanoparticle, a targeting moiety specific for a cell type of interest, a light-activated drug delivery system, wherein the nanoparticles are associated with the targeting moiety and the light-activated drug delivery system.
    Type: Application
    Filed: April 22, 2011
    Publication date: October 31, 2013
    Applicants: CHILDREN'S HOSPITAL BOSTON, MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Sebastien Febvay, Davide Maurizio Marini, David E. Clapham
  • Publication number: 20130102495
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: May 30, 2012
    Publication date: April 25, 2013
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David E. CLAPHAM, Dejian REN
  • Publication number: 20130072403
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: January 30, 2012
    Publication date: March 21, 2013
    Applicant: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • Publication number: 20130067603
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: February 10, 2012
    Publication date: March 14, 2013
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • Patent number: 8211666
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Grant
    Filed: October 30, 2003
    Date of Patent: July 3, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: David E. Clapham, Dejian Ren
  • Patent number: 8110668
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: February 7, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • Publication number: 20090249499
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: October 2, 2008
    Publication date: October 1, 2009
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • Publication number: 20080311578
    Abstract: The present invention provides methods and compositions for expressing eukaryotic membrane proteins.
    Type: Application
    Filed: January 15, 2008
    Publication date: December 18, 2008
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong A. Chong, Magdalene M. Moran, David E. Clapham
  • Patent number: 7339029
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: March 4, 2008
    Assignee: Children's Medical Center Corporation
    Inventors: Deijan Ren, David E. Clapham, David L. Garbers, Timothy A. Quill
  • Publication number: 20040157292
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: October 30, 2003
    Publication date: August 12, 2004
    Applicant: Children's Medical Center
    Inventors: David E. Clapham, Dejian Ren
  • Patent number: 5260578
    Abstract: A scanning confocal microscope (50) capable of providing ultraviolet (UV) excitation. The optical train substantially corrects scanning and focusing errors over the wavelength range that includes UV and visible wavelengths. In a particular embodiment, the lenses (27, 30') in the common path portion of the optical train are corrected for chromatically induced scanning errors while extra lenses (60, 65) are provided in the forward UV path to correct for focusing errors due to longitudinal chromatic (visible/UV) aberration.
    Type: Grant
    Filed: April 30, 1992
    Date of Patent: November 9, 1993
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Allison C. Bliton, David E. Clapham, James D. Lechleiter